Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity

Maturitas

Volumn 33, Issue 3, 1999, Pages 259-269

  Abbey, Mavis ^a   Owen, Alice ^b   Suzakawa, Michio ^a   Roach, Paul ^a   Nestel, Paul J ^c  

^a CSIRO   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Lipoproteins; Plasma; Women

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; ESTROGEN; GESTAGEN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; RETINOL; TRIACYLGLYCEROL;

ARTICLE; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MENOPAUSE; ORAL DRUG ADMINISTRATION; OXIDATION; RADIOIMMUNOASSAY;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ESTRADIOL; FATTY ACIDS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIPIDS; LIPOPROTEIN(A); LIPOPROTEINS; LIPOPROTEINS, LDL; MENOPAUSE; MIDDLE AGED; OXIDATION-REDUCTION; RECEPTORS, LDL; TRIGLYCERIDES; VITAMINS;

EID: 0032748784     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00054-7     Document Type: Article

References (63)

1. Dawber TR, editor. Lipids and atherosclerotic disease, In: The Framingham Study: The Epidemiology of Atherosclerotic Disease. London: Cambridge University Press, 1980. p. 129-141.
2. Kushwaha R.S. Female sex hormones and lipoprotein metabolism. Curr. Opin. Lipidol. 3:1992;167-172.
3. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 265:1991;1861-1867.
4. Witztum J.L. The role of monocytes and oxidized LDL in atherosclerosis. Ather. Rev. 21:1990;59-69.
5. Semenkovich C.F., Ostlund R.E. Jr. Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2. Biochemistry. 26:1987;4987-4992.
6. Angelin B., Olivecrona H., Reihner E., Rudling M., Stahlberg D., Eriksson M., Ewerth S., Henriksson P., Einarsson K. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology. 103:1992;1657-1663.
7. Sparrow C.P., Parthasarathy S., Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264:1989;2599-2604.
8. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1991;1325-1332.
9. Princen H.M.G., van Poppel G., Vogelezang C., Buytenhek R., Kok F.J. Supplementation with vitamin E but not β-carotene in vivo protect low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler. Thromb. 12:1992;554-562.
10. Abbey M., Nestel P.J., Baghurst P.A. Antioxidant vitamins and low density lipoprotein oxidation. Am. J. Clin. Nutr. 58:1993;525-532.
11. Nakano M., Sugioka K., Naito I., Takekoshi S., Niki E. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochem. Biophys. Res. Comm. 142:1987;919-924.
12. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 210:1987;37-39.
13. Maziere C., Auclair M., Ronveaux M.F., Salmon S., Santus R., Maziere J.C. Estrogens inhibit copper and cell mediated modification of low density lipoprotein. Atherosclerosis. 89:1991;175-182.
14. Rufici V.A., Khachadurian A.K. The inhibition of low density lipoprotein oxidation by 17-β-estradiol. Metabolism. 41:1992;1110-1114.
15. Leszczynski D.E., Schafer R.M. Characterisation of steroid hormone association with human plasma lipoproteins. Steroids. 54:1989;37-53.
16. Wagner J.D., Clarkson T.B., St. Clair R.W., Schwenke D.C., Shively C.A., Adams M.R. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin. Invest. 88:1991;1995-2002.
17. 2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin. Chem. 28:1982;1379-1388.
18. DeLong D.M., DeLong E.R., Wood P.D., Lippel K., Rifkind B.M. A comparison of methods for the estimation of plasma low and very low density lipoprotein cholesterol. J. Am. Med. Assoc. 256:1986;2372-2377.
19. Wang X.L., Wilcken D.E., Dudman N.P. An indirect sandwich ELISA for Lp[a] in serum and dried blood spots. Clin. Chim. Acta. 207:1992;73-86.
20. Yang C.S., Lee M.-J. Methodology of plasma retinol, tocopherol, and carotenoid assays in cancer prevention studies. J. Nutr. Growth Cancer. 4:1987;19-27.
21. Abbey M., Clifton P., Kestin M., Belling B., Nestel P. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis. 10:1990;85-94.
22. Nichols A.V., Krauss R.M., Musliner T.A. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128:1986;417-431.
23. Clifton P.M., Noakes M., Nestel P.J. LDL particle size and LDL and HDL cholesterol changes with dietary fat and cholesterol in healthy subjects. J. Lipid Res. 39:1998;1799-1804.
24. Blanche P.J., Gong E.L., Forte T.M., Nichols A.V. Characterisation of human high density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665:1981;408-419.
25. Roach P.D., Hosking J., Clifton P.M., Bais R., Kusenic B., Coyle P., Wight M.B., Thomas D.W., Nestel P.J. The effects of hypercholesterolaemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells. Atherosclerosis. 103:1993;245-254.
26. Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., Hokanson J.E., Krauss R.M., Beaudrie K., Cone J.T. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 128:1986;181-209.
27. Kerry N., Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis. 140:1998;341-347.
28. Clifton P.M., Chang L., Mackinnon A.M. Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyzer. Anal. Biochem. 172:1988;165-168.
29. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6:1989;67-75.
30. Wills E.D. Lipid peroxide formation in microsomes: general considerations. Biochem. J. 113:1969;315-324.
31. Barter P.J., Jones M.E. Rate of exchange of esterified cholesterol between human plasma and high density lipoproteins. Atherosclerosis. 34:1979;67-74.
32. Suzukawa M., Abbey A., Howe P.C., Nestel P.J. Effects of fish oil fatty acids on low density lipoprotein size, oxidisability, and uptake by macrophages. J. Lipid Res. 36:1995;473-484.
33. Suzukawa M., Abbey M., Clifton P., Nestel P.J. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis. 110:1994;77-86.
34. Stevenson J.C., Crook D., Godsland I.F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 98:1993;83-90.
35. Bhathena R.K., Anklesaria B.S., Ganatra A.M., Pinto R. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br. J. Clin. Pharmacol. 45:1998;170-172.
36. Roach P.D., Kerry N.L., Whiting M.J., Nestel P.J. Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit. Atherosclerosis. 101:1993;157-164.
37. Steyn K., Fourie J., Benade A.J., Roussouw J.E., Langenhoven M.L., Joubert G., Chalton D.O. Factors associated with high density lipoprotein cholesterol in a population with high density lipoprotein cholesterol levels. Arteriosclerosis. 9:1989;390-397.
38. DeLignieres B., Basdevant A., Thomas G., Thalabard J.-C., Mercier-Bodard C., Conard J., Guyene T.-T., Mairon N., Corvol P., Guy-Grand B., Mauvais-Jarvis P., Sitrok-Ware R. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J. Clin. Endocrinol. Metab. 62:1986;536-541.
39. Taskinen M.-R., Puolakka J., Pyorala T., Luotola H., Bjorn M., Kaariainen J., Lahdenpera S., Ehnholm C. Hormone replacement therapy lowers plasma Lp(a) concentrations. Arterioscler. Thromb. Vasc. Biol. 1215:1996;1221.
40. Nenseter M.S., Volden V., Berg T., Drevon C.A., Ose L., Tunstad S. The effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur. J. Clin. Invest. 26:1996;1062-1068.
41. Julius U., Fritsch H., Rehal E., Fucker K., Leonhardt W., Hanefeld M. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women. Clin. Invest. 72:1994;502-507.
42. Bruschi F., Meschia M., Soma M., Perotti D., Paoletti R., Crosignani P.G. Lipoprotein(a) and other lipids after oopherectomy and estrogen replacement therapy. Obstet. Gynecol. 88:1996;950-954.
43. 2 levels in normal men. J. Clin. Endocrinol. Metab. 78:1994;855-861.
44. Silliman K., Tall A.R., Kretchmer N., Forte T.M. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism. 42:1993;1592-1599.
45. Walsh B.W., Li H., Sacks F.M. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J. Lipid Res. 35:1994;2083-2093.
46. Tilly-Kiesi M., Kahri J., Pyorala T., Puolakka J., Luotola H., Lappi M., Lahdenperä S., Taskinen M.-R. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens on postmenopausal women. Atherosclerosis. 129:1997;249-259.
47. Mattsson L.A., Samsoie G., von Shoultz B., Uvebrant M., Wiklund I. Transdermally administered oestradiol combined with oral methoxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women. Br. J. Obstet. Gynaecol. 100:1993;450-453.
48. Bartens W., Wanner C. Lipoprotein(a): new insights into an atherogenic lipoprotein. Clin. Invest. 72:1994;558-567.
49. Dahlen G.H. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis. 108:1994;111-126.
50. Nestel P., Noakes M., Belling B., McArthur R., Clifton P., Janus E., Abbey M. Plasma lipoprotein lipid and Lp(a) changes with the substitution of elaidic acid for oleic acid in the diet. J. Lipid Res. 33:1992;1029-1036.
51. Kim C.J., Jang H.C., Cho D.H., Min Y.K. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler. Thromb. 14:1994;275-281.
52. Rajman I., Maxwell S., Cramb R., Kendall M. Particle size: the key to the atherogenic lipoprotein? Q. J. Med. 87:1994;709-720.
53. Campos H., McNamara J.R., Wilson P.W.F., Ordovas J.M., Schaefer E.J. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal women and postmenopausal women. J. Clin. Endocrinol. Metab. 67:1988;30-35.
54. van der Mooren M.J., de Graaf J., Demacker P.N.M., de Haan A.F.J., Rolland R. Changes in the low density lipoprotein profile during 17β-estradiol dydrogesterone therapy in postmenopausal women. Metabolism. 43:1994;799-802.
55. Manning J.M., Campos G., Edwards I.J., Wagner W.D., Wagner J.D., Adams M.R., Parks J.S. Effects of hormone replacement modalities on low density lipoprotein composition and distribution in ovariectomized cynomolgus monkeys. Atherosclerosis. 121:1996;217-229.
56. Campos H., Arnold K.S., Balestra M.E., Innerarity T.L., Krauss R.M. Differences in receptor binding of LDL subclasses. Arterioscler. Thromb. Vasc. Biol. 16:1996;794-801.
57. Abbey M., Belling G.B., Noakes M., Hirata F., Nestel P.J. Oxidation of low-density lipoproteins: intraindividual variability and the effect if dietary linoleate supplementation. Am. J. Clin. Nutr. 57:1993;391.
58. Keaney J.F., Shwaery G.T., Xu A., Nicolosi R.J., Loscalzo J., Foxall T.L., Vita J.A. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
59. Sack M.N., Rader D.J., Cannon R.O. Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet. 343:1994;269-270.
60. McManus J., McEneny J., Thompson W., Young I.S. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis. 135:1997;73-81.
61. Wakasuki A., Ikenoue N., Sagara Y. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas. 28:1998;229-234.
62. Chait A., Brazg R.L., Tribble D.L., Krauss R.M. Susceptibility of small, dense, low density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94:1993;350-356.
63. van der Mooren M.J., de Rijke Y.B., Demacker P.N.M., Rolland R., Blom H.J. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil. Steril. 67:1997;73.